|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Net sales | |||||
| Cost of sales | |||||
| Gross profit | |||||
| Selling, general and administrative | |||||
| Engineering - research and development | |||||
| Loss associated with impairment of long-lived assets | |||||
| Operating income | |||||
| Interest expense, net | |||||
| Other income (expense), net | |||||
| Income before income taxes | |||||
| Income tax expense | |||||
| Net income | |||||
| Basic earnings per share attributable to common stockholders | |||||
| Diluted earnings per share attributable to common stockholders | |||||
| Other comprehensive (loss) income, net of tax: | |||||
| Foreign currency translation | |||||
| Pension and OPEB liability adjustment | |||||
| Interest rate swaps | |||||
| Total other comprehensive (loss) income, net of tax | |||||
| Comprehensive income, net of tax | |||||
Loading...
